Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

NIIT Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Growth is driven by AI-led programs which now contribute about 9% of overall revenue, with continued scaling of AI training and new GrowthPro offerings. Key…

23 Sept 2026

Capital Small Finance Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Non-Punjab geography advances grew over 30% YoY, indicating strong market expansion. Key concall takeaways from Capital Small Finance Bank Ltd's Q1 FY27…

23 Sept 2026

Suryoday Small Finance Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Focus on individual loans, with individual loans contributing around 80% of monthly onboarding; planned reduction of JLG exposure over 1-1.5 years. Key concall…

23 Sept 2026

Aurum Proptech Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Aurum PropTech has created a war chest of around INR 200 crores as capital for the Housing.com acquisition, primarily funded by promoters subscribing to shares…

23 Sept 2026

Sagar Cements Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

No major CapEx planned beyond routine maintenance (~₹30-40 crore annually) till end of FY 2028, focusing on leveraging existing capacity and improving…

23 Sept 2026

Dynamic Cables Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

As of June 30, 2026, Dynamic Cables Limited's order book stands at INR 811 crores, providing strong revenue visibility. Key concall takeaways from Dynamic…

23 Sept 2026

Rossari Biotech Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Volume growth in Q1 was about 10%, with the remainder of top-line growth from price increases (Page 12). Key concall takeaways from Rossari Biotech Ltd's Q1…

23 Sept 2026

Route Mobile Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

New product portfolio (RCS, WhatsApp, non-SMS solutions) growing robustly at 14% YoY and 11% QoQ, seen as growth engine (Page 4, 12). Key concall takeaways…

23 Sept 2026

Heritage Foods Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

The goal is to increase VAP contribution to roughly 50% of revenues by FY30, up from 39% last financial year. Key concall takeaways from Heritage Foods Ltd's…

23 Sept 2026

Sterling & Wilson Renewable Energy Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Large order pipelines worth INR45,000 to INR50,000 crores (India focused) indicate robust future opportunities. Key concall takeaways from Sterling & Wilson…

23 Sept 2026

Tatva Chintan Pharma Chem Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Q1 FY27 saw a 43% year-on-year revenue growth and 25% sequential increase, indicating strong momentum. Key concall takeaways from Tatva Chintan Pharma Chem…

23 Sept 2026

Canara Robeco Asset Management Company Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Operating revenue grew 20% year-on-year in Q1 FY27, driven by yield improvement and controlled costs. Key concall takeaways from Canara Robeco Asset Management…

23 Sept 2026

Bansal Wire Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Capacity utilization historically at 85%-90%, starting the year with 20%-25% excess capacity to support growth without excess strain. Key concall takeaways…

23 Sept 2026

Stylam Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Existing plant capacity has slight unused capacity (5-10%) for laminates; acrylic plant currently underutilized. Key concall takeaways from Stylam Industries…

23 Sept 2026

Birla Corporation Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

No deferral of capacity expansion plans; currently operating at over 90% capacity, indicating no constraint for growth. Key concall takeaways from Birla…

23 Sept 2026

Cyient DLM Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Current order book stands at approximately INR 2,600 crores (INR 25,989 million as per Q1 FY27). Key concall takeaways from Cyient DLM Ltd's Q1 FY27 earnings…

23 Sept 2026

Madhya Bharat Agro Products Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

. Key concall takeaways from Madhya Bharat Agro Products Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

23 Sept 2026

Medplus Health Services Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Q1 operating EBITDA was INR651 million (3.5%), with confidence that efforts will close gaps in upcoming quarters. Key concall takeaways from Medplus Health…

23 Sept 2026

Tips Music Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Content acquisition budget for FY '27 is INR 90–100 crores, supporting volume growth via new music releases. Key concall takeaways from Tips Music Ltd's Q1…

23 Sept 2026

Thyrocare Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…

23 Sept 2026